The news directly pertains to Progyny (PGNY) as Keybanc has lowered its price target for the stock. However, the Overweight rating is maintained, indicating that the analyst still believes the stock will outperform its peers. This could have a neutral impact on the stock's price in the short term as the lowered price target might be seen as a negative, but the maintained Overweight rating could offset this.